Investigating the pertussis resurgence in England and Wales, and options for future control
Tóm tắt
In 2012 England and Wales experienced a resurgence of pertussis and an increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced whole cell (wP) primary vaccine despite continued high coverage for the primary series and pre-school aP booster. We developed a mathematical model to describe pertussis transmission dynamics in England and Wales since the 1950s and used it to investigate the cause of the resurgence and the potential impact of additional vaccination strategies. An age-structured, compartmental, deterministic model of the pertussis transmission dynamics was fitted to 60 continuous years of age-stratified pertussis notification data in England and Wales. The model incorporated vaccine-induced and natural immunity and differentiated between vaccine-induced protection against clinical disease and infection. The degree of protection of wP vaccine against infection was estimated to be higher than that of aP vaccine. Furthermore, the duration of protection for natural and wP-induced immunity was likely to be at least 15 years, but for aP vaccine it could be as low as 5 years. Model results indicated that the likely cause of the resurgence was the replacement of wP by less efficacious aP vaccine and that an elevated level of pertussis would continue. The collapse in wP vaccine coverage in the 1970s and resultant outbreaks in the late 1970s and early 1980s could not explain the resurgence. Addition of an adolescent or toddler booster was predicted to have little impact on the disease in infants. Our findings support the recent recommendation by the World Health Organisation that countries currently using wP vaccine for primary immunisation should not change to aP vaccine unless additional strategies to control infant disease such as maternal immunisation can be assured. Improved pertussis vaccines that provide better protection against infection are needed.
Tài liệu tham khảo
WHO. Weekly epidemiological record. 23 May 2014, vol. 89, 21. pp. 221–236.
Amirthalingam G, Gupta S, Campbell H. Pertussis immunisation and control in England and Wales, 1957 to 2012: a historical review. Euro Surveill. 2013;18:1–9.
Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014;384:1521–8.
Campbell H, Amirthalingam G, Andrews N, Fry NK, George RC, Harrison TG, Miller E. Accelerating control of pertussis in England and Wales. Emerg Infect Dis. 2012;18:38–47.
Joint Committee on Vaccination and Immunisation. Minutes of the meeting held on 6 February 2004. London: Department of Health. http://webarchive.nationalarchives.gov.uk/20130107105354/http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_095072.pdf. Accessed 9 Aug 2016.
Warfel JM, Merkel TJ. The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Rev Vaccines. 2014;13:1241–52.
Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014;111:787–92.
Department of Health (UK). Immunisation against infectious disease - the green book. London: Department of Health; 2006.
Águas R, Gonçalves G, Gomes MGM, Aguas R. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis. 2006;6:112–7.
Anderson R, May R. Directly transmitted infections diseases: control by vaccination. Science. 1982;215:1053–60.
Great Britain. General Register Office. The Registrar-General’s statistical review of England and Wales, Vol. 60. London: HMSO; 1970.
Great Britain Office of Population Censuses and Surveys. Statistics of infectious diseases. Series MB2. London: HMSO; 1975.
Public Health England. Notifications of infectious diseases (NOIDs). 2014. https://www.gov.uk/government/collections/notifications-of-infectious-diseases-noids. Accessed 9 Aug 2016.
Department of Health and Social Security. Statistical Bulletin on Vaccination and Immunisation (JCVI (86) 35). 1987.
National Health Service. NHS immunisation statistics, England. 2015. http://www.hscic.gov.uk/catalogue/PUB18472. Accessed 9 Aug 2016.
Public Health England. Cover of vaccination evaluated rapidly programme. 2016. https://www.gov.uk/government/collections/vaccine-uptake#cover-of-vaccination-evaluated-rapidly-programme. Accessed 9 Aug 2016.
Mossong JJ, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, Heijne J, Sadkowska-Todys M, Rosinska M, Edmunds WJ. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5:e74.
Van Hoek AJ, Andrews N, Campbell H, Amirthalingam G, Edmunds WJ, Miller E. The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young. PLoS One. 2013;8:e76180.
Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005;24(Supplement):S58–61.
Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 2009;5:e1000647.
Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol. 2015;11:e1004138.
Hood J, Murphey D, Dunn J. Hospital-acquired pertussis among newborns --- Texas, 2004. MMWR. 2008;57:600–3.
Gerbie MV, Tan TQ. Pertussis disease in new mothers: effect on young infants and strategies for prevention. Obstet Gynecol. 2009;113:399–401.
Wendelboe E, Njamkepo E, Bourillon A, Floret D, Gaudelus J, Gerber M, Grimprel E, Greenberg D, Halperin S, Liese J, Muñoz-Rivas F, Teyssou R, Guiso N, Van Rie A, Group. IPS. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293–9.
Preziosi M. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine. 2003;21:1853–61.
Sheridan SL, Frith K, Snelling TL, Grimwood K, McIntyre PB, Lambert SB. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Rev Vaccines. 2014;13:1081–106.
Sheridan SL, McCall BJ, Davis CA, Robson JMB, Hull BP, Selvey CE, Ware RS, Grimwood K, Lambert SB. Acellular pertussis vaccine effectiveness for children during the 2009–2010 pertussis epidemic in Queensland. Med J Aust. 2014;200:334–8.
Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367:1012–9.
Misegades LK, Winter K, Harriman K, Talarico J, Messonnier NE, Clark TA, Martin SW. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308:2126–32.
Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, Skoff TH. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics. 2013;131:e1047–52.
Baxter R, Bartlett J, Rowhani-Rahbar A, Fireman B, Klein NP. Effectiveness of pertussis vaccines for adolescents and adults: case-control study. BMJ. 2013;347:f4249.
Koepke R, Eickhoff JC, Ayele RA, Petit AB, Schauer SL, Hopfensperger DJ, Conway JH, Davis JP. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand. J Infect Dis. 2014;210:942–53.
Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine. 2015;33:5794–800.
Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med. 2015;13:146.
Van Hoek AJ, Campbell H, Andrews N, Vasconcelos M, Amirthalingam G, Miller E. The burden of disease and health care use among pertussis cases in school aged children and adults in England and Wales; a patient survey. PLoS One. 2014;9:e111807.
WHO. Pertussis Vaccines: WHO Position Paper – August 2015. Weekly epidemiological record. 2015. p. 433–60.